Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies

Authors Wang P, Li J, Qiu S, Wen H, Du J

Received 24 June 2014

Accepted for publication 5 August 2014

Published 31 December 2014 Volume 2015:11 Pages 59—66

DOI https://doi.org/10.2147/NDT.S69918

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Roger Pinder


Peifu Wang, Jilai Li, Shi Qiu, Honfeng Wen, Jichen Du

Department of Neurology, Aerospace Center Hospital, Peking University Aerospace Clinical College, Beijing, People’s Republic of China

Background and purpose: Published data on the relationship of hormone replacement therapy (HRT) with Parkinson’s disease (PD) were inconclusive. Thus, a systematic meta-analysis of observational studies was performed to clarify this topic.
Methods: The databases of PubMed and EMBASE were searched for case–control or cohort studies published up till June 2, 2014. Meta-analysis of the relative risks (RRs) with 95% confidence intervals (CIs) was estimated using random-effects models.
Results: A final total of ten case–control and four cohort studies were included in our meta-analysis. The overall combined RR of PD for ever users versus never users of HRT was 1.00 (95% CI: 0.84–1.20). Limited to those subjects who only use estrogen, a similar trend was detected (RR: 0.95, 95% CI: 0.69–1.30). In the subgroup analysis by study design, no significant association was observed in case–control studies (RR: 0.79, 95% CI: 0.62–1.02), whereas a positive association was found in cohort studies (RR: 1.24, 95% CI: 1.10–1.40). In further analysis according to study quality, an inverse association was found in the low-quality group (RR: 0.58, 95% CI: 0.40–0.82), whereas a positive association was found in the high-quality group (RR: 1.16, 95% CI: 1.02–1.31).
Conclusion: In summary, our results of meta-analysis do not support a protective role of HRT in female PD development.

Keywords: Parkinson’s disease, hormone replacement therapy, hormone meta-analysis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]